Accelerating translational research through Cardiff University’s Clinical Innovation pipeline

Lead Research Organisation: Cardiff University

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.
 
Description Life Sciences Bridging Fund - Pathfinder
Amount £50,672 (GBP)
Organisation Welsh Assembly 
Sector Public
Country United Kingdom
Start 06/2017 
End 12/2017
 
Description The role of antibody in enabling cell mediated control of HCMV-infection
Amount £610 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 01/2019 
End 12/2021
 
Description Wellcome Trust ISSF
Amount £50,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2018 
End 03/2019
 
Description Wellcome Trust ISSF
Amount £50,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2018 
End 03/2019
 
Description AP Densply 
Organisation Dentsply Sirona
PI Contribution Technology scoping
Collaborator Contribution Technology scoping
Impact Prospective bid to EPSRC
Start Year 2018
 
Description AP QuayPharma 
Organisation QuayPharma
PI Contribution Technology scoping
Collaborator Contribution Technology scoping
Impact Prospective collaborative bid for EPSRC funding
Start Year 2018
 
Description WA Heraeus 
Organisation Heraeus
Country Germany 
Sector Private 
PI Contribution Liposomal antibiotic development
Collaborator Contribution Biomechanical properties of bone cement
Impact n/a
Start Year 2017
 
Description WA Zimmer Biomet 
Organisation Zimmer Biomet
Country Unknown 
Sector Private 
PI Contribution Technical scoping of liposomal antibiotics
Collaborator Contribution Technical scoping of bone cement
Impact n/a
Start Year 2017
 
Title METHODS AND COMPOSITIONS FOR THE TREATMENT OF HCMV 
Description Provided herein are compositions and methods for the treatment of HCMV infection in a subject. 
IP Reference WO2015073788 
Protection Patent application published
Year Protection Granted 2015
Licensed No
Impact License in negotiation